Back
Aptorum Group Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
48
APM
Aptorum Group
Last Price:
4.80
Seasonality Move:
-18.34%
Sell
22
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.87
Seasonality Move:
-9.46%
Sell
48
Aptorum Group (APM)
is a Sell
Is Aptorum Group a Buy, Sell or Hold?
- The current Aptorum Group [APM] share price is $4.71. The Score for APM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- APM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.88. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APM Stock Price Chart
What is Aptorum Group's stock price today?
-
The Aptorum Group share price today is $4.71
The current trend is relatively stagnant and APM is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
APM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 49.01 | Sell |
Chaikin Money Flow: | 1507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.3 - 4.88) | Buy |
Bollinger Bands (100): | (2.54 - 7.6) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 33.33 | Sell |
Chaikin Money Flow: | -562191 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.95 - 1.09) | Sell |
Bollinger Bands (100): | (1.01 - 1.45) | Sell |
APM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.53 | Buy |
20-day SMA: | 4.66 | Buy |
50-day SMA: | 5.11 | Sell |
200-day SMA: | 3.52 | Buy |
8-day EMA: | 4.58 | Buy |
20-day EMA: | 4.66 | Buy |
50-day EMA: | 4.99 | Sell |
200-day EMA: | 4.33 | Buy |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.94 | Sell |
20-day SMA: | 1 | Sell |
50-day SMA: | 1.06 | Sell |
200-day SMA: | 0.94 | Sell |
8-day EMA: | 0.93 | Sell |
20-day EMA: | 0.99 | Sell |
50-day EMA: | 1.07 | Sell |
200-day EMA: | 1.07 | Sell |
Aptorum Group Earnings Growth & APM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $365.70 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.
Aptorum Group Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |